News NICE backs Amgen's Blincyto in rare leukaemia Drug will also be available to children via Cancer Drugs Fund.
News UK court overturns AbbVie Humira patents Decision paves way for cheaper competitor in autumn 2018.
News US drug revenues far exceed R&D spend - report Analysis questions industry's rationale for high US prices.
Events Partner Content Viral Safety - 25-27 April 2017 - Amserdam, The Netherlands Viral Safety conference
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
